Report #2835169

Overview

Sex

Male

Age

Age unknown

State

SC

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Wrong Route of Administration; Administration to adult patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a adult male patient who received MMR (Priorix) (batch number X3M3D) for prophylaxis. On an unknown date, the patient received Priorix (intramuscular). On an unknown date, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: Wrong Route of Administration) and inappropriate age at vaccine administration (Verbatim: Administration to adult patient). The outcome of the subcutaneous injection formulation administered by other route and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-MAR-2025 The pharmacist stated that the Priorix was administered intramuscularly instead of subcutaneous and to an adult patient which led to subcutaneous injection formulation administered by other route and inappropriate age at vaccine administration.